Snowball logo
logo
6002

Tibet Rhodiola Pharmaceutical Holding Co

600211 SHG
¥40.05¥0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
2,138.62,554.63,134.32,806.72,950.62,993
COGS
225.8204.7158.7162.1213.3198.4
Gross Profit
1,912.82,349.92,975.72,644.62,737.32,794.5
Operating Expenses & Income
Operating Income
256.8464.7899.11,160.5924.71,039
Total Operating Expenses
1,6561,885.22,076.61,484.21,812.61,806.9
R&D Expenses
60.8688.1317.3528.9462.1790.76
Selling General & Admin Expenses
99.46132.5124122.146.77511.2
Earnings from Continuing Operations
Interest Expense
(4.328635)(14.78)(11.95)(9.292)(12.75)(24.57)
Interest Income
2.66806314.3245.7859.2780.5248.88
Income Tax Expense
41.8288.0887.9595.01123.692.24
Net Income
Net Income
208.9369.8800.91,051.3937.9967.4
Supplemental
EBIT
259.2478.2910.11,161.4924.7-
EBITDA
340.6547.4978.21,235.61,003.4-
In millions of CNY, except % and values per 1 share